Indications and uses
Acne
Acne
Store in a cool dark place
ARSENICUM BROMATUM HPUS 6X and Higher
Acne
Condition listed above or as directed by the physician
Adults- Take 4 or 6 Tablets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose.
This product is to be used for self-limiting conditions
If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional
As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product
Keep this and all medication out of reach of children
Do not use if capseal is broken or missing.
Close the cap tightly after use.
Lactose
Store in a cool dark place
www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com
Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 15631-0523-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| 15631-0523-7 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-53ef-f424-e053-dadaa90a57ce | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15631-0523-0 | ARSENICUM BROMATUM | 1 in 1 BLISTER PACK | TABLET | 1 | 1 | |
| 15631-0523-1 | ARSENICUM BROMATUM | 4 in 1 BLISTER PACK | TABLET | 4 | 1 | |
| 15631-0523-2 | ARSENICUM BROMATUM | 50 in 1 CONTAINER | TABLET | 50 | 1 | |
| 15631-0523-3 | ARSENICUM BROMATUM | 100 in 1 CONTAINER | TABLET | 100 | 1 | |
| 15631-0523-4 | ARSENICUM BROMATUM | 250 in 1 CONTAINER | TABLET | 250 | 1 | |
| 15631-0523-5 | ARSENICUM BROMATUM | 500 in 1 CONTAINER | TABLET | 500 | 1 | |
| 15631-0523-6 | ARSENICUM BROMATUM | 1000 in 1 CONTAINER | TABLET | 1000 | 1 | |
| 15631-0523-7 | ARSENICUM BROMATUM | 10000 in 1 CONTAINER | TABLET | 10000 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 15631-0523 | ARSENICUM BROMATUM TABLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC] | 1 | Legacy NDC, 8 package rows | 20160116_ba16f90e-23c5-4c0f-bf15-bd12c68733e4.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 15631-0523 | 15631-0523-0, 15631-0523-1, 15631-0523-2, 15631-0523-3, 15631-0523-4, 15631-0523-5, 15631-0523-6, 15631-0523-7 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARSENIC TRIBROMIDE | 41CN475O7F | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 82ae24be-87cb-4a37-ba06-73e08c4284ef | ba16f90e-23c5-4c0f-bf15-bd12c68733e4 | 2015-12-31 | Warnings | 82ae24be-87cb-4a37-ba06-73e08c4284ef ba16f90e-23c5-4c0f-bf15-bd12c68733e4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.